Literature DB >> 10817748

Postantibiotic suppression of growth of erythromycin A-susceptible and -resistant gram-positive bacteria by the ketolides telithromycin (HMR 3647) and HMR 3004.

W J Munckhof1, G Borlace, J D Turnidge.   

Abstract

We investigated the in vitro postantibiotic effects (PAEs) of the ketolides telithromycin (HMR 3647) and HMR 3004 and analyzed the results using the sigmoid E(max) model. Mean maximum telithromycin PAEs against erythromycin A-susceptible strains of Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus pneumoniae were 3. 7, 8.9, and 9.7 h, respectively, while maximum PAEs for erythromycin A-resistant strains were much shorter. Mean maximum HMR 3004 PAEs were 3.2 to 4.4 h for all species.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10817748      PMCID: PMC89952          DOI: 10.1128/AAC.44.6.1749-1753.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Evaluation of the E test, a novel method of quantifying antimicrobial activity.

Authors:  D F Brown; L Brown
Journal:  J Antimicrob Chemother       Date:  1991-02       Impact factor: 5.790

Review 2.  Prediction of antibiotic dosing intervals from in vitro susceptibility, pharmacokinetics and post-antibiotic effect: theoretical considerations.

Authors:  J D Turnidge
Journal:  Scand J Infect Dis Suppl       Date:  1990

3.  Interactions between HMR 3647, a new ketolide, and human polymorphonuclear neutrophils.

Authors:  D Vazifeh; A Preira; A Bryskier; M T Labro
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

4.  The postantibiotic effect of imipenem: relationship with drug concentration, duration of exposure, and MIC.

Authors:  W J Munckhof; D Olden; J D Turnidge
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

5.  Postantibiotic effect of roxithromycin, erythromycin, and clindamycin against selected gram-positive bacteria and Haemophilus influenzae.

Authors:  B Kuenzi; C Segessenmann; A U Gerber
Journal:  J Antimicrob Chemother       Date:  1987-11       Impact factor: 5.790

6.  In vitro activity of RU 64004, a new ketolide antibiotic, against gram-positive bacteria.

Authors:  T Schülin; C B Wennersten; R C Moellering; G M Eliopoulos
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

Review 7.  Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models.

Authors:  N H Holford; L B Sheiner
Journal:  Clin Pharmacokinet       Date:  1981 Nov-Dec       Impact factor: 6.447

8.  Ketolides lack inducibility properties of MLS(B) resistance phenotype.

Authors:  A Bonnefoy; A M Girard; C Agouridas; J F Chantot
Journal:  J Antimicrob Chemother       Date:  1997-07       Impact factor: 5.790

9.  Persistent effect of antibiotics on Staphylococcus aureus after exposure for limited periods of time.

Authors:  P J McDonald; W A Craig; C M Kunin
Journal:  J Infect Dis       Date:  1977-02       Impact factor: 5.226

Review 10.  Post-antibiotic effects in experimental infection models: relationship to in-vitro phenomena and to treatment of infections in man.

Authors:  W A Craig
Journal:  J Antimicrob Chemother       Date:  1993-05       Impact factor: 5.790

View more
  5 in total

1.  Telithromycin.

Authors:  J A Balfour; D P Figgitt
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Postantibiotic effects of ABT-773 and amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae.

Authors:  M M Neuhauser; J L Prause; L H Danziger; S L Pendland
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

Review 3.  Telithromycin.

Authors:  Keri Wellington; Stuart Noble
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 4.  The ketolides: a critical review.

Authors:  George G Zhanel; Michael Walters; Ayman Noreddin; Lavern M Vercaigne; Aleksandra Wierzbowski; John M Embil; Alfred S Gin; Stephen Douthwaite; Daryl J Hoban
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 5.  Progress in Niobium Oxide-Containing Coatings for Biomedical Applications: A Critical Review.

Authors:  Mir Saman Safavi; F C Walsh; Livia Visai; Jafar Khalil-Allafi
Journal:  ACS Omega       Date:  2022-03-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.